Since the pandemic, disruptions to the pharmaceutical supply chain have been exacerbated. A multi-stakeholder group in Canada is working diligently to mitigate the impact on patients. Significant strides toward monitoring and managing drug supply have been made with the creation of a tracking system for critical drugs. These are the shortages or discontinuation events expected to have the highest impact on Canada’s drug supply and overall health system.

• Examining the newly established national drug shortage list and how it will be used to communicate and act on potential shortages in the future
• Assessing current supply chain challenges impacting drug supply in Canada
• Identifying how stakeholders across the pharmaceutical supply chain and the healthcare system can assist with the prevention and mitigation of drug shortages
• Exploring how artificial intelligence can assist with real-time monitoring